| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMZN | Common Stock, par value $.01 per share | Options Exercise | $0 | +12.7K | +2.51% | $0.00 | 518K | Feb 21, 2025 | Direct | |
| transaction | AMZN | Common Stock, par value $.01 per share | Options Exercise | $0 | +2.6K | +0.5% | $0.00 | 521K | Feb 21, 2025 | Direct | |
| transaction | AMZN | Common Stock, par value $.01 per share | Sale | -$377K | -1.7K | -0.33% | $221.52 | 519K | Feb 21, 2025 | Direct | F1, F2 |
| transaction | AMZN | Common Stock, par value $.01 per share | Sale | -$356K | -1.6K | -0.31% | $222.31 | 517K | Feb 21, 2025 | Direct | F1, F3 |
| transaction | AMZN | Common Stock, par value $.01 per share | Sale | -$625K | -2.8K | -0.54% | $223.14 | 514K | Feb 21, 2025 | Direct | F1, F4 |
| holding | AMZN | Common Stock, par value $.01 per share | 6.58K | Feb 21, 2025 | Amazon.com 401(k) plan account |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMZN | Restricted Stock Unit Award | Options Exercise | $0 | -12.7K | -24.49% | $0.00 | 39K | Feb 21, 2025 | Common Stock, par value $.01 per share | 12.7K | $0.00 | Direct | F5, F6 |
| transaction | AMZN | Restricted Stock Unit Award | Options Exercise | $0 | -2.6K | -4.34% | $0.00 | 57.3K | Feb 21, 2025 | Common Stock, par value $.01 per share | 2.6K | $0.00 | Direct | F5, F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/07/2024. |
| F2 | Represents the weighted average sale price. The highest price at which shares were sold was $221.99 and the lowest price at which shares were sold was $221.00. |
| F3 | Represents the weighted average sale price. The highest price at which shares were sold was $222.97 and the lowest price at which shares were sold was $222.01. |
| F4 | Represents the weighted average sale price. The highest price at which shares were sold was $223.26 and the lowest price at which shares were sold was $223.14. |
| F5 | Converts into Common Stock on a one-for-one basis. |
| F6 | This award vests based upon the following vesting schedule: 3,980 shares on each of May 21, 2022, August 21, 2022, November 21, 2022, and February 21, 2023; 4,900 shares on each of May 21, 2023, August 21, 2023, and November 21, 2023; 4,920 shares on February 21, 2024; 12,640 shares on May 21, 2024; 12,660 shares on each of August 21, 2024, November 21, 2024, and February 21, 2025; and 9,760 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026. |
| F7 | This award vests based upon the following vesting schedule: 2,600 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,520 shares on May 21, 2025; 3,500 shares on each of August 21, 2025, November 21, 2025, and February 21, 2026; 2,860 shares on May 21, 2026; 2,840 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,980 shares on May 21, 2027; and 7,960 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028. |
The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.